1. Home
  2. HUMA vs XPER Comparison

HUMA vs XPER Comparison

Compare HUMA & XPER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • XPER
  • Stock Information
  • Founded
  • HUMA 2004
  • XPER 1990
  • Country
  • HUMA United States
  • XPER United States
  • Employees
  • HUMA N/A
  • XPER N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • XPER Semiconductors
  • Sector
  • HUMA Health Care
  • XPER Technology
  • Exchange
  • HUMA Nasdaq
  • XPER Nasdaq
  • Market Cap
  • HUMA 324.0M
  • XPER 310.9M
  • IPO Year
  • HUMA N/A
  • XPER 2003
  • Fundamental
  • Price
  • HUMA $1.71
  • XPER $6.76
  • Analyst Decision
  • HUMA Strong Buy
  • XPER Strong Buy
  • Analyst Count
  • HUMA 7
  • XPER 2
  • Target Price
  • HUMA $10.00
  • XPER $13.50
  • AVG Volume (30 Days)
  • HUMA 7.6M
  • XPER 450.9K
  • Earning Date
  • HUMA 11-07-2025
  • XPER 11-05-2025
  • Dividend Yield
  • HUMA N/A
  • XPER N/A
  • EPS Growth
  • HUMA N/A
  • XPER N/A
  • EPS
  • HUMA N/A
  • XPER N/A
  • Revenue
  • HUMA $818,000.00
  • XPER $475,219,000.00
  • Revenue This Year
  • HUMA N/A
  • XPER N/A
  • Revenue Next Year
  • HUMA $1,686.52
  • XPER $6.47
  • P/E Ratio
  • HUMA N/A
  • XPER N/A
  • Revenue Growth
  • HUMA N/A
  • XPER N/A
  • 52 Week Low
  • HUMA $1.15
  • XPER $5.69
  • 52 Week High
  • HUMA $6.77
  • XPER $11.08
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 48.43
  • XPER 55.00
  • Support Level
  • HUMA $1.65
  • XPER $6.44
  • Resistance Level
  • HUMA $1.90
  • XPER $6.75
  • Average True Range (ATR)
  • HUMA 0.10
  • XPER 0.22
  • MACD
  • HUMA -0.01
  • XPER -0.01
  • Stochastic Oscillator
  • HUMA 42.03
  • XPER 74.19

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About XPER Xperi Inc.

Xperi Inc is a consumer and entertainment technology company. Its offering comprises a portfolio of software and services. The company creates extraordinary experiences at home and on the go for millions of consumers around the world, enabling audiences to connect with content in a more intelligent, immersive, and personal way. Its business is divided into four categories based on the products delivered and customers served: Pay-TV, Consumer Electronics, Connected Car, and Platform Solutions. It generates the majority of its revenue from the Consumer Electronics segment. Its also have sales in Japan, Europe and Middle East, China, South Korea, Latin America, and Others.

Share on Social Networks: